Depletion of conventional CD4+ T cells is required for robust priming and dissemination of tumor antigen-specific CD8+ T cells in the setting of anti-CD4 therapy is a research paper published in Journal for ImmunoTherapy of Cancer (2024). On theSindex it has a DataRank of 0.330. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →All of Us Research Program
Grant: P30 CA023108
All of Us Research Program
Grant: R01 CA269455
All of Us Research Program
Grant: R01CA22502
All of Us Research Program
Grant: R01CA254042
All of Us Research Program
Grant: R01CA271553
All of Us Research Program
Grant: T32 AI007363
NCI NIH HHS
Grant: P30 CA016058
NCI NIH HHS
Grant: R01 CA225028
National Institutes of Health
Grant: 3R01CA269455-01A1S1
Investigating virus- and vaccine-specific T cells in glioblastoma
National Institutes of Health
Grant: 5T32AI007363-23
Immunobiology of Myeloid and Lymphoid Cells
National Institutes of Health
Grant: 3P30CA023108-41S8
Cancer Center Support Grant
National Institutes of Health
Grant: 1R01CA271553-01A1
Activating Native Tumor Immunity with IL-33 Armored CARs
National Institutes of Health
Grant: 5R01CA254042-03
Sustaining Tissue Resident Memory T cells
FWCI
1.42
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals